NO895199L - Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinsystemforbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinsystemforbindelser.

Info

Publication number
NO895199L
NO895199L NO89895199A NO895199A NO895199L NO 895199 L NO895199 L NO 895199L NO 89895199 A NO89895199 A NO 89895199A NO 895199 A NO895199 A NO 895199A NO 895199 L NO895199 L NO 895199L
Authority
NO
Norway
Prior art keywords
preparation
therapeutically effective
system compounds
quinoline system
analogue procedure
Prior art date
Application number
NO89895199A
Other languages
English (en)
Other versions
NO895199D0 (no
NO173994C (no
NO173994B (no
Inventor
Masatoshi Yamato
Kuniko Hashigaki
Original Assignee
Kanto Ishi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanto Ishi Pharma Co Ltd filed Critical Kanto Ishi Pharma Co Ltd
Publication of NO895199D0 publication Critical patent/NO895199D0/no
Publication of NO895199L publication Critical patent/NO895199L/no
Publication of NO173994B publication Critical patent/NO173994B/no
Publication of NO173994C publication Critical patent/NO173994C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO895199A 1988-12-27 1989-12-21 Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser med kondensert kinolinsystem NO173994C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33067488 1988-12-27
JP1282208A JPH02256667A (ja) 1988-12-27 1989-10-30 縮合キノリン系化合物およびその製造方法

Publications (4)

Publication Number Publication Date
NO895199D0 NO895199D0 (no) 1989-12-21
NO895199L true NO895199L (no) 1990-08-17
NO173994B NO173994B (no) 1993-11-22
NO173994C NO173994C (no) 1994-03-02

Family

ID=26554516

Family Applications (1)

Application Number Title Priority Date Filing Date
NO895199A NO173994C (no) 1988-12-27 1989-12-21 Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser med kondensert kinolinsystem

Country Status (10)

Country Link
EP (1) EP0376166A1 (no)
JP (1) JPH02256667A (no)
KR (1) KR900009645A (no)
AU (1) AU619633B2 (no)
DK (1) DK653889A (no)
FI (1) FI896176A0 (no)
HU (1) HU206200B (no)
IL (1) IL92813A (no)
NO (1) NO173994C (no)
NZ (1) NZ232008A (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01228965A (ja) * 1988-03-10 1989-09-12 Mect Corp 縮合キノリン系化合物及び縮合アクリジン系化合物、それらの製造法ならびにそれらの化合物を有効成分とする抗癌剤
JPH0692410B2 (ja) * 1988-08-30 1994-11-16 キッセイ薬品工業株式会社 新規なベンゾフロキノリン誘導体
AU640135B2 (en) * 1990-03-20 1993-08-19 Wellcome Foundation Limited, The Hetero polycyclic biocidal compounds and their use in medicine
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
US5681958A (en) * 1995-06-07 1997-10-28 Shaman Pharmaceuticals, Inc. Cryptolepine analogs with hypoglycemic activity
DE4439329A1 (de) * 1994-11-04 1996-05-09 Agfa Gevaert Ag Neue Gelbkuppler vom Typ Indolo [3,2-b] chinoline und ihre Verwendung in einem farbfotografischen Entwicklungsverfahren
US5741926A (en) * 1997-02-12 1998-04-21 Shaman Pharmaceuticals, Inc. Aniline derivatives having antihyperglycemic activity
JP4327915B2 (ja) * 1998-03-30 2009-09-09 株式会社デ・ウエスタン・セラピテクス研究所 スルフォンアミド誘導体
ES2215893T3 (es) * 2000-03-17 2004-10-16 Bristol-Myers Squibb Pharma Company Derivados de beta-aminoacidos como inhibidores de metaloproteasas de matriz y tnf-alfa.
ES2223827T3 (es) * 2000-06-06 2005-03-01 Pfizer Products Inc. Derivados de tiofeno utiles como agentes anticancerigenos.
EP1687304A1 (en) * 2003-11-20 2006-08-09 Crystax Pharmaceuticals S.L. Substituted quinolines for the treatment of cancer
AU2005282554A1 (en) 2004-09-07 2006-03-16 Wyeth 6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents
WO2009123241A1 (ja) 2008-03-31 2009-10-08 株式会社レナサイエンス プラスミノーゲンアクチベーターインヒビター－１阻害剤
CA2757615C (en) 2009-03-31 2018-07-17 Renascience Co., Ltd. Plasminogen activator inhibitor-1 inhibitor
US10092537B2 (en) 2013-04-15 2018-10-09 Renascience Co., Ltd. Use for PAI-1 inhibitor
CN103497211B (zh) * 2013-10-15 2016-07-20 中国海洋大学 吲哚并喹啉衍生物及其制备方法和应用
US11691983B2 (en) 2016-06-22 2023-07-04 Idemitsu Kosan Co., Ltd. Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes
CN115160310B (zh) * 2022-05-10 2023-06-23 中国人民解放军北部战区总医院 作为CDK2/Topo I抑制剂的白叶藤碱衍生物及其制备方法和抗肿瘤的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ200715A (en) * 1982-05-24 1986-06-11 New Zealand Dev Finance Acridine derivatives and pharmaceutical compositions containing such
JPS63101369A (ja) * 1986-10-17 1988-05-06 Mect Corp インデノキノリン系化合物、その製造法及びその化合物を有効成分とする抗癌剤
JPH01228965A (ja) * 1988-03-10 1989-09-12 Mect Corp 縮合キノリン系化合物及び縮合アクリジン系化合物、それらの製造法ならびにそれらの化合物を有効成分とする抗癌剤

Also Published As

Publication number Publication date
IL92813A (en) 1994-05-30
HUT52774A (en) 1990-08-28
EP0376166A1 (en) 1990-07-04
IL92813A0 (en) 1990-09-17
NO895199D0 (no) 1989-12-21
NZ232008A (en) 1990-11-27
HU896774D0 (en) 1990-03-28
AU619633B2 (en) 1992-01-30
HU206200B (en) 1992-09-28
FI896176A0 (fi) 1989-12-21
KR900009645A (ko) 1990-07-05
NO173994C (no) 1994-03-02
DK653889A (da) 1990-06-28
DK653889D0 (da) 1989-12-21
AU4680989A (en) 1990-07-05
NO173994B (no) 1993-11-22
JPH02256667A (ja) 1990-10-17

Similar Documents

Publication Publication Date Title
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO872946D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO171063C (no) Analogifremgangsmaate til fremstilling av terapeutisk akseptable, alkoksy-substituerte dihydrobenzopyran-2-karboksylatderivater
NO894842D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazoler.
NO162113C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser.
NO165397C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO895199L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinsystemforbindelser.
NO900032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO864110L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO169963C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
NO161066C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO912797L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme karbostirilderivater.
NO894949D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzopyranylpyrrolinonderivater.
NO164172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tienokondenserte forbindelser.
NO167980C (no) Analogifremgangsmaate for fremstilling av tienoimidazol-derivater.
NO168530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.
NO160203C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fenotiazin-forbindelser.
NO903397D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd.
NO160712C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-forbindelser.
NO892469D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-forbindelser.
NO153053C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fenoletere.
NO863225D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzodioxepaner.
NO169337C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme nafthalenderivater.